# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 21, "Diabetes Obes Metab .", "", "<http://ctro/data#Publication_80501> <http://ctro/data#hasJournal> \"Diabetes Obes Metab .\"."
1, PublicationYear, 22, 26, "2017", "", "<http://ctro/data#Publication_80501> <http://ctro/data#hasPublicationYear> \"2017\"."
8, Title, 109, 307, "Adding fast - acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes : A randomized , 18 - week , open - label , phase 3 trial ( onset 3 ) .", "", "<http://ctro/data#Publication_80501> <http://ctro/data#hasTitle> \"Adding fast - acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes : A randomized , 18 - week , open - label , phase 3 trial ( onset 3 ) .\"."
2, InsulinAspart, 130, 144, "insulin aspart", "", 
3, Insulin, 148, 161, "basal insulin", "", 
4, Type2Diabetes, 220, 235, "type 2 diabetes", "", 
5, Randomized, 240, 250, "randomized", "", 
6, Duration, 253, 262, "18 - week", "", 
7, OpenLabel, 265, 277, "open - label", "", 
9, Author, 308, 318, "Rodbard HW", "", "<http://ctro/data#Publication_80501> <http://ctro/data#hasAuthor> \"Rodbard HW\"."
10, Author, 327, 337, "Tripathy D", "", "<http://ctro/data#Publication_80501> <http://ctro/data#hasAuthor> \"Tripathy D\"."
11, Author, 352, 372, "Vidrio Vel á zquez M", "", "<http://ctro/data#Publication_80501> <http://ctro/data#hasAuthor> \"Vidrio Vel á zquez M\"."
12, Author, 381, 391, "Demissie M", "", "<http://ctro/data#Publication_80501> <http://ctro/data#hasAuthor> \"Demissie M\"."
13, Author, 400, 408, "Tamer SC", "", "<http://ctro/data#Publication_80501> <http://ctro/data#hasAuthor> \"Tamer SC\"."
14, Author, 417, 427, "Pileti č M", "", "<http://ctro/data#Publication_80501> <http://ctro/data#hasAuthor> \"Pileti č M\"."
127, USA, 513, 521, "Maryland", "", "<http://ctro/data#Population_80531> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
128, USA, 588, 593, "Texas", "", "<http://ctro/data#Population_80531> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
129, USA, 645, 650, "Texas", "", 
15, Mexico, 705, 711, "Mexico", "", "<http://ctro/data#Population_80531> <http://ctro/data#hasCountry> <http://ctro/data#Mexico>."
16, Country, 752, 759, "Denmark", "", "<http://ctro/data#Country_80543> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Country>. <http://ctro/data#Population_80531> <http://ctro/data#hasCountry> <http://ctro/data#Country_80543>."
17, Country, 800, 808, "Slovenia", "", "<http://ctro/data#Country_80544> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Country>. <http://ctro/data#Population_80531> <http://ctro/data#hasCountry> <http://ctro/data#Country_80544>."
37, ObjectiveDescription, 817, 976, "To confirm glycaemic control superiority of mealtime fast - acting insulin aspart ( faster aspart ) in a basal - bolus ( BB ) regimen vs basal - only insulin .", "", "<http://ctro/data#ClinicalTrial_80513> <http://ctro/data#hasObjectiveDescription> \"To confirm glycaemic control superiority of mealtime fast - acting insulin aspart ( faster aspart ) in a basal - bolus ( BB ) regimen vs basal - only insulin .\"."
108, InsulinAspart, 870, 898, "fast - acting insulin aspart", "", "<http://ctro/data#Medication_80575> <http://ctro/data#hasDrug> <http://ctro/data#InsulinAspart>."
19, InsulinAspart, 901, 914, "faster aspart", "", 
20, Insulin, 954, 974, "basal - only insulin", "", "<http://ctro/data#Insulin_80619> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Insulin>. <http://ctro/data#Medication_80618> <http://ctro/data#hasDrug> <http://ctro/data#Insulin_80619>."
21, OpenLabel, 1009, 1021, "open - label", "", "<http://ctro/data#ClinicalTrial_80513> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
22, Randomized, 1024, 1034, "randomized", "", "<http://ctro/data#ClinicalTrial_80513> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
23, Duration, 1037, 1046, "18 - week", "", "<http://ctro/data#ClinicalTrial_80513> <http://ctro/data#hasCTduration> \"18 - week\"."
24, Multicenter, 1055, 1077, "51 sites ; 6 countries", "", "<http://ctro/data#ClinicalTrial_80513> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
98740, Precondition, 1082, 1088, "adults", "", "<http://ctro/data#Population_80531> <http://ctro/data#hasPrecondition> \"adults\". <http://ctro/data#Population_80531> <http://ctro/data#hasPrecondition> \"with inadequately controlled type 2 diabetes\". <http://ctro/data#Population_80531> <http://ctro/data#hasPrecondition> \"receiving basal insulin and oral antidiabetic drugs\"."
25, NumberPatientsCT, 1097, 1100, "236", "", "<http://ctro/data#ClinicalTrial_80513> <http://ctro/data#hasNumberPatientsCT> \"236\"."
98740, Precondition, 1103, 1147, "with inadequately controlled type 2 diabetes", "", 
27, Type2Diabetes, 1132, 1147, "type 2 diabetes", "", "<http://ctro/data#ClinicalTrial_80513> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
28, Type2Diabetes, 1150, 1153, "T2D", "", 
30, Mean, 1156, 1160, "mean", "", 
31, HbA1c, 1161, 1185, "glycosylated haemoglobin", "", 
32, HbA1c, 1188, 1193, "HbA1c", "", 
33, Percentage, 1221, 1222, "%", "", 
35, ConcentrationUnit, 1244, 1254, "mmol / mol", "", 
98740, Precondition, 1259, 1310, "receiving basal insulin and oral antidiabetic drugs", "", 
36, Insulin, 1269, 1282, "basal insulin", "", 
38, OralAntidiabeticAgent, 1287, 1310, "oral antidiabetic drugs", "", 
39, Duration, 1321, 1329, "8 - week", "", 
40, Frequency, 1352, 1364, "once - daily", "", 
42, Insulin, 1365, 1378, "basal insulin", "", 
43, Randomized, 1391, 1404, "randomization", "", 
156, AllocationRatio, 1405, 1410, "1 : 1", "", "<http://ctro/data#AllocationRatio_80517> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio>. <http://ctro/data#ClinicalTrial_80513> <http://ctro/data#hasAllocationRatio> <http://ctro/data#AllocationRatio_80517>."
44, InsulinAspart, 1439, 1452, "faster aspart", "", 
47, NumberPatientsArm, 1461, 1464, "116", "", "<http://ctro/data#Arm_80582> <http://ctro/data#hasNumberPatientsArm> \"116\"."
41, Frequency, 1486, 1498, "once - daily", "", "<http://ctro/data#Intervention_80606> <http://ctro/data#hasFrequency> \"once - daily\"."
45, Insulin, 1499, 1512, "basal insulin", "", 
48, NumberPatientsArm, 1521, 1524, "120", "", "<http://ctro/data#Arm_80591> <http://ctro/data#hasNumberPatientsArm> \"120\"."
46, Metformin, 1539, 1548, "metformin", "", "<http://ctro/data#Medication_80625> <http://ctro/data#hasDrug> <http://ctro/data#Metformin>."
49, HbA1c, 1572, 1577, "HbA1c", "", 
50, TimePoint, 1590, 1598, "baseline", "", 
51, TimePoint, 1605, 1615, "18   weeks", "", 
52, PostprandialPlasmaGlucose, 1662, 1689, "postprandial plasma glucose", "", 
53, PostprandialPlasmaGlucose, 1692, 1695, "PPG", "", 
54, PostprandialPlasmaGlucose, 1709, 1720, "overall PPG", "", 
55, BodyWeight, 1747, 1753, "weight", "", 
172, EndPointDescription, 1777, 1791, "adverse events", "", 
56, Hypoglycemia, 1794, 1816, "hypoglycaemic episodes", "", 
57, HbA1c, 1829, 1834, "HbA1c", "", "<http://ctro/data#Endpoint_80545> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
69, BaseLineValue, 1850, 1855, "7 . 9", "", "<http://ctro/data#Outcome_80632> <http://ctro/data#hasBaselineValue> \"7 . 9\"."
58, Percentage, 1856, 1857, "%", "", "<http://ctro/data#Endpoint_80545> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
71, BaseLineValue, 1860, 1866, "63 . 2", "", 
64, ConcentrationUnit, 1869, 1879, "mmol / mol", "", 
73, ResultMeasuredValue, 1885, 1890, "6 . 8", "", "<http://ctro/data#Outcome_80632> <http://ctro/data#hasResultMeasuredValue> \"6 . 8\"."
59, Percentage, 1891, 1892, "%", "", 
74, ResultMeasuredValue, 1895, 1901, "50 . 7", "", 
65, ConcentrationUnit, 1904, 1914, "mmol / mol", "", 
70, BaseLineValue, 1937, 1942, "7 . 9", "", "<http://ctro/data#Outcome_80659> <http://ctro/data#hasBaselineValue> \"7 . 9\"."
60, Percentage, 1943, 1944, "%", "", 
72, BaseLineValue, 1947, 1953, "63 . 2", "", 
66, ConcentrationUnit, 1956, 1966, "mmol / mol", "", 
75, ResultMeasuredValue, 1972, 1977, "7 . 7", "", "<http://ctro/data#Outcome_80659> <http://ctro/data#hasResultMeasuredValue> \"7 . 7\"."
61, Percentage, 1978, 1979, "%", "", 
76, ResultMeasuredValue, 1982, 1988, "60 . 7", "", 
67, ConcentrationUnit, 1991, 2001, "mmol / mol", "", 
193, Insulin, 2004, 2016, "basal - only", "", 
77, DiffGroupAbsValue, 2087, 2095, "- 0 . 94", "", "<http://ctro/data#DiffBetweenGroups_80686> <http://ctro/data#hasDiffGroupAbsValue> \"- 0 . 94\"."
63, Percentage, 2096, 2097, "%", "", 
78, ConfIntervalDiff, 2100, 2119, "- 1 . 17 ; - 0 . 72", "", "<http://ctro/data#DiffBetweenGroups_80686> <http://ctro/data#hasConfIntervalDiff> \"- 1 . 17 ; - 0 . 72\"."
80, DiffGroupAbsValue, 2124, 2132, "- 10 . 3", "", 
68, ConcentrationUnit, 2135, 2145, "mmol / mol", "", 
79, ConfIntervalDiff, 2148, 2166, "- 12 . 8 ; - 7 . 8", "", 
81, PvalueDiff, 2171, 2182, "P  < . 0001", "", "<http://ctro/data#DiffBetweenGroups_80686> <http://ctro/data#hasPvalueDiff> \"P  < . 0001\"."
106250, ObservedResult, 2185, 2379, "Reductions from baseline in overall mean 2 - hour PPG and overall PPG increment for all meals ( self - measured plasma glucose profiles ) were statistically significant in favour of BB treatment", "", "<http://ctro/data#Outcome_80695> <http://ctro/data#hasObservedResult> \"Reductions from baseline in overall mean 2 - hour PPG and overall PPG increment for all meals ( self - measured plasma glucose profiles ) were statistically significant in favour of BB treatment\". <http://ctro/data#Outcome_80723> <http://ctro/data#hasObservedResult> \"Reductions from baseline in overall mean 2 - hour PPG and overall PPG increment for all meals ( self - measured plasma glucose profiles ) were statistically significant in favour of BB treatment\". <http://ctro/data#Outcome_85300> <http://ctro/data#hasObservedResult> \"Reductions from baseline in overall mean 2 - hour PPG and overall PPG increment for all meals ( self - measured plasma glucose profiles ) were statistically significant in favour of BB treatment\". <http://ctro/data#Outcome_85327> <http://ctro/data#hasObservedResult> \"Reductions from baseline in overall mean 2 - hour PPG and overall PPG increment for all meals ( self - measured plasma glucose profiles ) were statistically significant in favour of BB treatment\"."
82, TimePoint, 2201, 2209, "baseline", "", 
83, Mean, 2221, 2225, "mean", "", "<http://ctro/data#Mean_80552> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_80550> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_80552>. <http://ctro/data#Mean_80557> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_80555> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_80557>."
84, PostprandialPlasmaGlucose, 2226, 2238, "2 - hour PPG", "", "<http://ctro/data#Endpoint_80550> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#PostprandialPlasmaGlucose>."
85, PostprandialPlasmaGlucose, 2243, 2254, "overall PPG", "", "<http://ctro/data#Endpoint_80555> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#PostprandialPlasmaGlucose>."
86, PvalueDiff, 2382, 2393, "P  < . 0001", "", "<http://ctro/data#DiffBetweenGroups_85354> <http://ctro/data#hasPvalueDiff> \"P  < . 0001\". <http://ctro/data#DiffBetweenGroups_85363> <http://ctro/data#hasPvalueDiff> \"P  < . 0001\"."
87, SevereHypoglycemia, 2398, 2444, "Severe / blood glucose confirmed hypoglycaemia", "", "<http://ctro/data#Endpoint_80560> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#SevereHypoglycemia>."
90, ResultMeasuredValue, 2452, 2458, "12 . 8", "", "<http://ctro/data#Outcome_80750> <http://ctro/data#hasResultMeasuredValue> \"12 . 8\"."
91, ResultMeasuredValue, 2462, 2467, "2 . 0", "", "<http://ctro/data#Outcome_80777> <http://ctro/data#hasResultMeasuredValue> \"2 . 0\"."
96, BioAndMedicalUnit, 2468, 2508, "episodes per patient - years of exposure", "", "<http://ctro/data#BioAndMedicalUnit_80563> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_80560> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_80563>."
88, InsulinDose, 2513, 2532, "total daily insulin", "", "<http://ctro/data#InsulinDose_80566> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#InsulinDose>. <http://ctro/data#Endpoint_80565> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#InsulinDose_80566>."
92, ResultMeasuredValue, 2535, 2540, "1 . 2", "", "<http://ctro/data#Outcome_80804> <http://ctro/data#hasResultMeasuredValue> \"1 . 2\"."
93, ResultMeasuredValue, 2544, 2549, "0 . 6", "", "<http://ctro/data#Outcome_80831> <http://ctro/data#hasResultMeasuredValue> \"0 . 6\"."
97, BioAndMedicalUnit, 2550, 2556, "U / kg", "", "<http://ctro/data#BioAndMedicalUnit_80568> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_80565> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_80568>."
98752, BodyWeight, 2563, 2569, "weight", "", "<http://ctro/data#Endpoint_80570> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BodyWeight>."
214, Increment, 2577, 2582, "1 . 8", "", "<http://ctro/data#Outcome_80858> <http://ctro/data#hasChangeValue> \"1 . 8\"."
215, Increment, 2586, 2591, "0 . 2", "", "<http://ctro/data#Outcome_80885> <http://ctro/data#hasChangeValue> \"0 . 2\"."
98, Kg, 2594, 2596, "kg", "", "<http://ctro/data#Endpoint_80570> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg>."
167, FixedCombDrug, 2617, 2619, "BB", "", 
217, Insulin, 2630, 2642, "basal - only", "", 
103, ConclusionComment, 2669, 2863, "In T2D , faster aspart in a BB regimen provided superior glycaemic control as compared with basal - only insulin , but with an increase in the frequency of hypoglycaemia and modest weight gain .", "", "<http://ctro/data#ClinicalTrial_80513> <http://ctro/data#hasConclusionComment> \"In T2D , faster aspart in a BB regimen provided superior glycaemic control as compared with basal - only insulin , but with an increase in the frequency of hypoglycaemia and modest weight gain .\"."
99, Type2Diabetes, 2672, 2675, "T2D", "", 
111, InsulinAspart, 2678, 2691, "faster aspart", "", 
102, Insulin, 2774, 2781, "insulin", "", 
100, Hypoglycemia, 2825, 2838, "hypoglycaemia", "", 
101, WeightGain, 2850, 2861, "weight gain", "", 
104, PMID, 3012, 3020, "28345792", "", "<http://ctro/data#Publication_80501> <http://ctro/data#hasPMID> \"28345792\"."
